Ariskem Pharmaceuticals Private Limited, a active private limited company, was established on 24 February 2021 in Kesnand, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290PN2021PTC198904. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Employing 10 professional, Its leadership includes Prince Raj (Director), Ramji Prasad (Additional Director), Mukesh Kumar (Additional Director). Past directors included Ajay Kumar, Kanchan Sinha. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Shashank Shekhar, Gate No 459 460 Fl. No. B 201, Optima Heights Haveli, Kesnand, Maharashtra, 412207.
U24290PN2021PTC198904
198904
24 February 2021
₹1.50 M
₹1.50 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Ariskem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prince Raj | Director | 24 Feb 2021 | Current |
| Ramji Prasad | Additional Director | 13 Feb 2023 | Current |
| Mukesh Kumar | Additional Director | 13 Feb 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Feb 2023 | Past |
| Pramod Abcsdd | Director | 13 Feb 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Ariskem Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ariskem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2021 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ariskem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ariskem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ariskem Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ariskem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Ariskem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Ramji Prasad was appointed as a Additional Director was appointed as a Additional Director on 13 Feb 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.
Progress on Mukesh Kumar was appointed as a Additional Director was appointed as a Additional Director on 13 Feb 2023 & has been associated with this company since 2 years 10 months . was documented.
Progress on A charge with Others amounted to Rs. 1.00 M with Charge ID 100518203 was registered on 27 Dec 2021. was documented.
Progress on Prince Raj was appointed as a Director was appointed as a Director on 24 Feb 2021 & has been associated with this company since 4 years 10 months . was documented.
The CIN of Ariskem Pharmaceuticals Private Limited is U24290PN2021PTC198904.
Ariskem Pharmaceuticals Private Limited is headquartered at C/O Shashank Shekhar, Gate No 459 460 Fl. No. B 201, Optima Heights Haveli, Kesnand, Maharashtra, 412207.
Ariskem Pharmaceuticals Private Limited was incorporated on 24 February 2021.
The current directors of Ariskem Pharmaceuticals Private Limited are
The primary industry of Ariskem Pharmaceuticals Private Limited is Pharma.
Ariskem Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ariskem Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX